Advertisement

Predictors of electrocardiographic screening failure for the subcutaneous implantable cardioverter-defibrillator in children: A prospective multicenter study

Published:January 05, 2018DOI:https://doi.org/10.1016/j.hrthm.2018.01.004

      Background

      Subcutaneous implantable cardioverter-defibrillator (SICD) shows promise for select patients at risk of sudden cardiac death. However, patients need to pass an electrocardiographic (ECG) screening (ECG-S) test before they can receive an SICD. Predictors of ECG-S failure in children are unclear.

      Objective

      The purpose of this study was to identify the incidence and predictive factors for failure of ECG-S in children.

      Methods

      Patients 18 years and younger with a preexisting ICD underwent ECG-S for SICD. ECG and demographic data were analyzed for factors predictive of failure.

      Results

      Seventy-three patients (mean age 14.2 ± 3.3 years; range 5–18 years) with hypertrophic cardiomyopathy (n = 24, 33%), long QT syndrome (n =18, 25%), other inherited arrhythmia syndromes (n = 20, 27%), congenital heart disease (n = 9, 12%), and miscellaneous conditions (n = 2) with an existing transvenous ICD underwent prospective ECG-S. Nineteen (26%) failed ECG-S. Failed patients had a longer corrected QT (QTc) interval (457 ms vs 425 ms; P = .03), a longer QRS duration (120 ms vs 98 ms; P = .04), and a lower ratio of R-wave to T-wave amplitudes (R:T ratio) in lead aVF (4 vs 5; P = .001). Multivariable logistic regression identified QTc interval (odds ratio [OR] 4.31; P = .04), QRS duration (OR 4.93; P = .03), R:T ratio in lead aVF (OR 3.13; P = .08) as predictors of failure. A risk score with 1 point each for QTc interval >440 ms, QRS duration >120 ms, and R:T ratio <6.5 in lead aVF was associated with probability of failure of 15.4% (1 point), 47.4% (2 points), and 88.6% (3 points), respectively.

      Conclusion

      ECG-S failure for SICD occurred in 26% of children, which is higher than the reported incidence in adults. Factors predicting ECG-S failure included longer QTc interval, longer QRS duration, and lower R:T ratio in lead aVF.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Silka M.J.
        • Kron J.
        • Dunnigan A.
        • Dick II, M.
        • The Pediatric Electrophysiology Society
        Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients.
        Circulation. 1993; 87: 800-807
        • Berul C.I.
        • Van Hare G.F.
        • Kertesz N.J.
        • Dubin A.M.
        • Cecchin F.
        • Collins K.K.
        • Cannon B.C.
        • Alexander M.E.
        • Triedman J.K.
        • Walsh E.P.
        • Friedman R.A.
        Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients.
        J Am Coll Cardiol. 2008; 51: 1685-1691
        • Silvetti M.S.
        • Drago F.
        • Di Carlo D.
        • Placidi S.
        • Brancaccio G.
        • Carotti A.
        Cardiac pacing in paediatric patients with congenital heart defects: transvenous or epicardial?.
        Europace. 2013; 15: 1280-1286
        • van Rees J.B.
        • de Bie M.K.
        • Thijssen J.
        • Borleffs C.J.
        • Schalij M.J.
        • van Erven L.
        Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials.
        J Am Coll Cardiol. 2011; 58: 995-1000
        • Alexander M.E.
        • Cecchin F.
        • Walsh E.P.
        • Triedman J.K.
        • Bevilacqua L.M.
        • Berul C.I.
        Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics.
        J Cardiovasc Electrophysiol. 2004; 15: 72-76
        • Links M.S.
        • Hill S.L.
        • Cliff D.L.
        • Swygman C.A.
        • Foote C.B.
        • Homoud M.K.
        • Wang P.J.
        • Estes III, A.M.
        • Berul C.I.
        Comparison of frequency of complications of implantable cardioverter-defibrillators in children versus adults.
        Am J Cardiol. 1999; 83: 263-266
        • Atallah J.
        • Erickson C.C.
        • Cecchin F.
        • Dubin A.M.
        • Law I.H.
        • Cohen M.I.
        • LaPage M.J.
        • Cannon B.C.
        • Chun T.U.H.
        • Freedenberg V.
        • Gierdalski M.
        • Berul C.I.
        • Pediatric and Congenital Electrophysiology Society (PACES)
        Multi-institutional study of implantable defibrillator lead performance in children and young adults: results of the Pediatric Lead Extractability and Survival Evaluation (PLEASE) study.
        Circulation. 2013; 127: 2393-2402
        • Moore J.P.
        • Mondésert B.
        • Lloyd M.S.
        • Cook S.C.
        • Zaidi A.N.
        • Pass R.H.
        • John A.S.
        • Fish F.A.
        • Shannon K.M.
        • Aboulhosn J.A.
        • Khairy P.
        Clinical experience with the subcutaneous implantable cardioverter-defibrillator in adults with congenital heart disease.
        Circ Arrhythm Electrophysiol. 2016; 9: e004338
        • Bardy G.H.
        • Smith W.M.
        • Hood M.A.
        • et al.
        An entirely subcutaneous implantable cardioverter-defibrillator.
        N Engl J Med. 2010; 363: 36-44
        • Nordkamp L.R.
        • Warnaars J.L.
        • Kooiman K.M.
        • de Groot J.R.
        • Rosenmöller B.R.
        • Wilde A.A.
        • Knops R.E.
        Which patients are not suitable for a subcutaneous ICD: incidence and predictors of failed QRS-T-wave morphology screening.
        J Cardiovasc Electrophysiol. 2014; 5: 494-499
        • Nordkamp L.R.
        • Dabiri Abkenari L.
        • Boersma L.V.
        • Maass A.H.
        • de Groot J.R.
        • van Oostrom A.J.
        • Theuns D.A.
        • Jordaens L.J.
        • Wilde A.A.
        • Knops R.E.
        The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort.
        J Am Coll Cardiol. 2012; 60: 1933-1939
        • Groh C.A.
        • Sharma S.
        • Pelchovitz D.J.
        • Bhave P.D.
        • Rhyner J.
        • Verma N.
        • Arora R.
        • Chicos A.B.
        • Kim S.S.
        • Lin A.C.
        • Passman R.S.
        • Knight B.P.
        Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator.
        Heart Rhythm. 2014; 11: 1361-1366
        • Park M.K.
        The Pediatric Cardiology Handbook.
        4th ed. Mosby, St. Louis, MO2010
        • Bordachar P.
        • Marquie C.
        • Pospiech T.
        • Pasquie J.-L.
        • Jalal Z.
        • Haissaguerre M.
        • Thambo J.-B.
        Subcutaneous implantable cardioverter defibrillators in children, young adults, and patients with congenital heart disease.
        Int J Cardiol. 2016; 203: 251-258
        • Sears S.F.
        • Hazelton A.G.
        • St Amant J.
        • et al.
        Quality of life in pediatric patients with implantable cardioverter defibrillators.
        Am J Cardiol. 2011; 107: 1023-1027
        • Alonso P.
        • Osca J.
        • Cano O.
        • Pimenta P.
        • Andres A.
        • Yaque J.
        • Millet J.
        • Rueda J.
        • Sancho-Tello M.J.
        The role of conventional and right-sided ECG screening for subcutaneous ICD in a tetralogy of Fallot population.
        Pacing Clin Electrophysiol. 2017; 40: 145-153